Fecal-free toxin detection remains the best way to detect Clostridium difficile infection by Planche, T, Wilcox, M, Walker, A

IMMUNOLOGICAL EVIDENCE FOR A PHYSARUM-BETA-TUBULIN POLYPEPTIDE POSSESSING AN ALPHA-TUBULIN-LIKE CARBOXYL TERMINUS by Gull, K, Wilcox, M, Birkett, C

Identification of tubulin isoforms in the plasmodium of Physarum polycephalum by in vitro microtubule assembly. by Roobol, A, Wilcox, M, Paul, E, Gull, K

Regarding "Clostridium difficile ribotype does not predict severe infection". by Walker, A, Eyre, D, Crook, D, Wilcox, M, Peto, T

Reply to Walk et al. by Walker, A, Eyre, D, Crook, D, Peto, T, Wilcox, M

Independent UK panel on breast cancer screening replies to michael baum by Marmot, M, Altman, D, Cameron, D, Dewar, J, Thompson, S, Wilcox, M

Independent UK Panel on Breast Cancer Screening replies to Michael Baum. by Marmot, M, Altman, G, Cameron, D, Dewar, J, Thompson, S, Wilcox, M

The benefits and harms of breast cancer screening: an independent review. by Marmot, MG, Altman, D, Cameron, D, Dewar, J, Thompson, S, Wilcox, M

The benefits and harms of breast cancer screening: an independent review. by Marmot, MG, Altman, D, Cameron, D, Dewar, J, Thompson, S, Wilcox, M

The benefits and harms of breast cancer screening Reply by Marmot, MG, Altman, D, Cameron, D, Dewar, J, Thompson, S, Wilcox, M, Canc, I

Management of patients with suspected infectious diarrhoea in hospitals in England. by Buchanan, J, Wordsworth, S, O'Connor, L, Pike, G, Walker, A, Wilcox, M, Crook, D

Clostridium difficile in England: can we stop washing our hands? - Authors' reply. by Eyre, D, Dingle, K, Didelot, X, Quan, T, Peto, T, Wilcox, M, Walker, A, Crook, D

Clostridium difficile mixed infection and reinfection. by Eyre, D, Walker, A, Griffiths, D, Wilcox, M, Wyllie, D, Dingle, K, Crook, D, Peto, T

Risk factors for Clostridium difficile acquisition in infants: importance of study design. by Stoesser, N, Martin, J, Mawer, D, Eyre, D, Walker, A, Peto, T, Crook, D, Wilcox, M

Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission. by Eyre, D, Fawley, W, Best, E, Griffiths, D, Stoesser, N, Crook, D, Peto, T, Walker, A, Wilcox, M

Contribution to Clostridium difficile transmission of symptomatic patients with toxigenic strains who are fecal toxin negative by Mawer, D, Eyre, D, Griffiths, D, Fawley, W, Martin, J, Quan, T, Peto, T, Crook, D, Walker, A, Wilcox, M

Patient and strain characteristics associated with Clostridium difficile transmission and adverse outcomes by Martin, J, Eyre, D, Fawley, W, Griffiths, D, Davies, K, Mawer, D, Peto, T, Crook, D, Walker, A, Wilcox, M

Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineage by Eyre, D, Didelot, X, Buckley, A, Freeman, J, Moura, I, Crook, D, Peto, T, Walker, A, Wilcox, M, Dingle, K

Comparison of control of Clostridium difficile infection in six English hospitals using whole-genome sequencing by Eyre, D, Fawley, W, Rajgopal, A, Settle, C, Mortimer, K, Goldenberg, S, Dawson, S, Crook, D, Peto, T, Walker, A, Wilcox, M

Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease by Eyre, D, Walker, A, Freeman, J, Baines, S, Fawley, W, Chilton, C, Griffiths, D, Vaughan, A, Crook, D, Peto, T, Wilcox, M